Skip to content
Home/Companies/Biotech/Animab
Animab

Animab

Biotech·Belgium·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Animab?

Animab is a Belgian Biotech company, currently owned by Seventure Partners since 2020.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Seventure Partners
Investor
Seventure Partners
AVF Fund · 2018 · VC

Key facts

HQBelgium
SectorBiotech
Websiteanimab.com

More Seventure Partners portfolio companies

From the same investor, across funds.

Clinical Microbiomics
Active
Launchmetrics
Active
Software
Idnow
Idnow
Active
CybersecurityGermany· 2026
Kainova Therapeutics
Kainova Therapeutics
Active
BiotechCanada· 2026
MaaT Pharma
MaaT Pharma
Active
BiotechFrance· 2026
Mediads
Mediads
Active
E-commerceFrance· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Animab?

Animab is currently owned by Seventure Partners, through AVF Fund, since 2020.

When did Seventure Partners acquire Animab?

Seventure Partners acquired Animab in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue